Search

everythinglearnresearchcommunity

for

Search:↓

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.

Syphilitic alopecia, linked to syphilis and high-risk sexual behavior, improves with penicillin treatment.

A new compound effectively inhibits human 5α-reductase 1.

Researchers created a lab model to study human hair growth, showing it can grow and self-regulate outside the body.

Topical eye β-blockers might cause hair loss, which usually gets better after stopping the medication.

Minoxidil increased small openings in blood vessel walls near growing hair in rats.

A new treatment for hair loss was tested and most participants saw their hair loss stop within 2-8 weeks, with up to 50% more hair after 4 months, and no side effects.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Almost all patients with chronic kidney disease not yet on dialysis have at least one skin problem.

Intestinal stem cells can help repair skin damage from radiation.

A new method accurately measures steroid hormones in a few hair strands and could help study chronic stress and hair loss.

Tip cryotherapy effectively treats idiopathic guttate hypomelanosis with minimal side effects.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Temporary hair loss can occur after brain AVM treatment but usually regrows in 8 weeks.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

People with pemphigus vulgaris and pemphigus foliaceus often have smaller sebaceous glands on their scalp.

In 2017, a new method was created to efficiently produce a topical antiandrogen, a compound used to treat excess sebum and acne, with a high yield and purity.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Oral minoxidil is a reasonably safe alternative for patients allergic to the topical form.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

Plasma is better than Ringer's lactate for hair graft survival and growth after transplantation.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.